Benzinga's Top Upgrades, Downgrades For November 20, 2019

Upgrades

  • For Canopy Growth Corp CGC, Bank of America upgraded the stock from Neutral to Buy. Canopy Growth earned ($1.08) in the second quarter, compared to ($3.70) in the year-ago quarter. Canopy Growth's market cap stands at $9.1 billion. The stock has a 52-week-high of $52.74 and a 52-week-low of $13.81. Canopy Growth's stock last closed at $15.31 per share.
  • Redburn upgraded the stock for Credit Suisse Group AG CS from Sell to Neutral. Credit Suisse Group earned $0.34 in the third quarter. The stock has a 52-week-high of $13.62 and a 52-week-low of $10.23. Credit Suisse Group's stock last closed at $13.06 per share.
  • Barclays upgraded the stock for easyJet PLC ESYJY from Underweight to Equal-Weight. The stock has a 52-week-high of $17.87 and a 52-week-low of $10.64. easyJet's stock last closed at $16.58 per share.
  • For Intelsat SA I, Raymond James upgraded the stock from Market Perform to Outperform. For the third quarter, Intelsat had an EPS of ($1.05), compared to year-ago quarter EPS of ($2.74). The total market value of Intelsat's outstanding shares is at $3.2 billion. The stock has a 52-week-high of $29.54 and a 52-week-low of $5.55. Intelsat's stock last closed at $6.09 per share.
  • RBC Capital upgraded the stock for Paycom Software Inc PAYC from Sector Perform to Outperform. In the third quarter, Paycom Software showed an EPS of $0.70, compared to $0.52 from the year-ago quarter. Paycom Software's market cap stands at $12.3 billion. The stock has a 52-week-high of $259.71 and a 52-week-low of $107.46. Paycom Software's stock last closed at $239.56 per share.
  • For Tradeweb Markets Inc TW, Goldman Sachs upgraded the stock from Neutral to Buy. Tradeweb Markets earned $0.27 in the third quarter. Tradeweb Markets's market cap stands at $9.2 billion. The stock has a 52-week-high of $50.48 and a 52-week-low of $33.68. Tradeweb Markets's stock last closed at $43.27 per share.

 

Downgrades

  • Evercore ISI Group downgraded the stock for Brixmor Property Group Inc BRX from Outperform to In-Line. For the third quarter, Brixmor Property Group had an EPS of $0.49, compared to year-ago quarter EPS of $0.42. Brixmor Property Group's market cap stands at $6.5 billion. The stock has a 52-week-high of $22.74 and a 52-week-low of $14.11. Brixmor Property Group's stock last closed at $22.50 per share.
  • KeyBanc changed the rating for Berry Petroleum Corp BRY from Sector Weight to Underweight. Berry Petroleum's market cap stands at $760.5 million. The stock has a 52-week-high of $13.99 and a 52-week-low of $7.58. Berry Petroleum's stock last closed at $8.90 per share.
  • For Berry Petroleum Corp BRY, Wells Fargo downgraded the stock from Outperform to Market Perform. The total market value of Berry Petroleum's outstanding shares is at $760.5 million. The stock has a 52-week-high of $13.99 and a 52-week-low of $7.58. Berry Petroleum's stock last closed at $8.90 per share.
  • For Berry Petroleum Corp BRY, BMO Capital downgraded the stock from Outperform to Market Perform. The total market value of Berry Petroleum's outstanding shares is at $760.5 million. The stock has a 52-week-high of $13.99 and a 52-week-low of $7.58. Berry Petroleum's stock last closed at $8.90 per share.
  • For Cboe Global Markets Inc CBOE, Goldman Sachs downgraded the stock from Buy to Neutral. For the third quarter, Cboe Global Markets had an EPS of $1.29, compared to year-ago quarter EPS of $1.06. Cboe Global Markets's market cap stands at $12.7 billion. The stock has a 52-week-high of $122.88 and a 52-week-low of $87.87. Cboe Global Markets's stock last closed at $122.51 per share.
  • Canaccord Genuity changed the rating for Castlight Health Inc CSLT from Buy to Hold. In the third quarter, Castlight Health showed an EPS of ($0.04), compared to $0.00 from the year-ago quarter. Castlight Health's market cap stands at $220.7 million. The stock has a 52-week-high of $4.15 and a 52-week-low of $1.21. Castlight Health's stock last closed at $1.43 per share.
  • For Evergy Inc EVRG, Bank of America downgraded the stock from Neutral to Underperform. Evergy earned $1.57 in the third quarter, compared to $1.34 in the year-ago quarter. Evergy's market cap stands at $14.5 billion. The stock has a 52-week-high of $67.81 and a 52-week-low of $54.57. Evergy's stock last closed at $64.78 per share.
  • Goldman Sachs changed the rating for Kohl's Corp KSS from Buy to Neutral. For the third quarter, Kohl's had an EPS of $0.74, compared to year-ago quarter EPS of $0.98. The total market value of Kohl's's outstanding shares is at $7.8 billion. The stock has a 52-week-high of $75.91 and a 52-week-low of $43.33. Kohl's's stock last closed at $47.01 per share.
  • Macquarie changed the rating for Qudian Inc QD from Neutral to Underperform. For the third quarter, Qudian had an EPS of $0.47, compared to year-ago quarter EPS of $0.32. The current market cap for Qudian is at $2.0 billion. The stock has a 52-week-high of $9.21 and a 52-week-low of $4.16. Qudian's stock last closed at $5.63 per share.
  • Citi changed the rating for RPC Inc RES from Neutral to Sell. RPC earned ($0.08) in the third quarter, compared to $0.19 in the year-ago quarter. The total market value of RPC's outstanding shares is at $888.3 million. The stock has a 52-week-high of $14.76 and a 52-week-low of $3.73. RPC's stock last closed at $3.84 per share.
  • Edward Jones changed the rating for Sherwin-Williams Co SHW from Buy to Hold. For the third quarter, Sherwin-Williams had an EPS of $6.65, compared to year-ago quarter EPS of $5.68. The current market cap for Sherwin-Williams is at $52.8 billion. The stock has a 52-week-high of $597.00 and a 52-week-low of $365.20. Sherwin-Williams's stock last closed at $584.03 per share.
  • For SunTrust Banks Inc STI, Janney Capital downgraded the stock from Buy to Neutral. In the third quarter, SunTrust Banks showed an EPS of $1.40, compared to $1.42 from the year-ago quarter. The current market cap for SunTrust Banks is at $30.3 billion. The stock has a 52-week-high of $71.75 and a 52-week-low of $46.05. SunTrust Banks's stock last closed at $70.68 per share.

 

Initiations

  • Oppenheimer initiated coverage on Alnylam Pharmaceuticals Inc ALNY with an Outperform rating. The price target for Alnylam Pharmaceuticals is set at $128.00. Alnylam Pharmaceuticals earned ($1.50) in the third quarter, compared to ($1.56) in the year-ago quarter. Alnylam Pharmaceuticals's market cap stands at $9.6 billion. The stock has a 52-week-high of $99.92 and a 52-week-low of $60.27. Alnylam Pharmaceuticals's stock last closed at $97.93 per share.
  • With a rating of Underperform, Oppenheimer initiated coverage on Amarin Corp PLC AMRN. The price target is set at $7.00 for Amarin Corp. For the third quarter, Amarin Corp had an EPS of ($0.01), compared to year-ago quarter EPS of ($0.06). The current market cap for Amarin Corp is at $5.8 billion. The stock has a 52-week-high of $24.67 and a 52-week-low of $11.78. Amarin Corp's stock last closed at $22.73 per share.
  • Goldman Sachs initiated coverage on The Brink's Co BCO with a Buy rating. The price target for Brink's is set at $108.00. For the third quarter, Brink's had an EPS of $1.05, compared to year-ago quarter EPS of $0.91. The current market cap for Brink's is at $4.1 billion. The stock has a 52-week-high of $93.81 and a 52-week-low of $59.08. Brink's's stock last closed at $90.06 per share.
  • With a rating of Buy, Deutsche Bank initiated coverage on Baker Hughes Co BKR. The price target is set at $32.00 for Baker Hughes. Baker Hughes's market cap stands at $21.9 billion. The stock has a 52-week-high of $28.65 and a 52-week-low of $20.09. Baker Hughes's stock last closed at $22.01 per share.
  • Guggenheim initiated coverage on CytomX Therapeutics Inc CTMX with a Buy rating. The price target for CytomX Therapeutics is set at $16.00. In the third quarter, CytomX Therapeutics showed an EPS of ($0.52), compared to ($0.53) from the year-ago quarter. The total market value of CytomX Therapeutics's outstanding shares is at $278.5 million. The stock has a 52-week-high of $19.75 and a 52-week-low of $5.10. CytomX Therapeutics's stock last closed at $5.18 per share.
  • Oppenheimer initiated coverage on Dana Inc DAN with an Outperform rating. The price target for Dana is set at $20.00. In the third quarter, Dana showed an EPS of $0.74, compared to $0.77 from the year-ago quarter. Dana's market cap stands at $2.3 billion. The stock has a 52-week-high of $20.96 and a 52-week-low of $11.57. Dana's stock last closed at $16.80 per share.
  • Morgan Stanley initiated coverage on Evercore Inc EVR with an Overweight rating. The price target for Evercore is set at $96.00. In the third quarter, Evercore showed an EPS of $1.26, compared to $1.23 from the year-ago quarter. The total market value of Evercore's outstanding shares is at $2.8 billion. The stock has a 52-week-high of $98.90 and a 52-week-low of $64.37. Evercore's stock last closed at $76.50 per share.
  • With a rating of Buy, Deutsche Bank initiated coverage on TechnipFMC PLC FTI. The price target is set at $33.00 for TechnipFMC. In the third quarter, TechnipFMC showed an EPS of $0.12, compared to $0.31 from the year-ago quarter. The stock has a 52-week-high of $28.57 and a 52-week-low of $18.20. TechnipFMC's stock last closed at $19.28 per share.
  • With a rating of Buy, Deutsche Bank initiated coverage on Halliburton Co HAL. The price target is set at $26.00 for Halliburton. Halliburton earned $0.34 in the third quarter, compared to $0.50 in the year-ago quarter. Halliburton's market cap stands at $16.8 billion. The stock has a 52-week-high of $33.11 and a 52-week-low of $16.97. Halliburton's stock last closed at $19.88 per share.
  • Morgan Stanley initiated coverage on Houlihan Lokey Inc HLI with a Equal-Weight rating. The price target for Houlihan Lokey is set at $49.00. For the second quarter, Houlihan Lokey had an EPS of $0.70, compared to year-ago quarter EPS of $0.70. Houlihan Lokey's market cap stands at $3.1 billion. The stock has a 52-week-high of $50.00 and a 52-week-low of $34.31. Houlihan Lokey's stock last closed at $47.70 per share.
  • With a rating of Sell, Deutsche Bank initiated coverage on Helmerich & Payne Inc HP. The price target is set at $34.00 for Helmerich & Payne. For the fourth quarter, Helmerich & Payne had an EPS of $0.38, compared to year-ago quarter EPS of $0.19. The total market value of Helmerich & Payne's outstanding shares is at $4.0 billion. The stock has a 52-week-high of $64.80 and a 52-week-low of $35.74. Helmerich & Payne's stock last closed at $38.41 per share.
  • Cantor Fitzgerald initiated coverage on Johnson & Johnson JNJ with an Overweight rating. The price target for Johnson & Johnson is set at $160.00. Johnson & Johnson earned $2.12 in the third quarter, compared to $2.05 in the year-ago quarter. The total market value of Johnson & Johnson's outstanding shares is at $347.5 billion. The stock has a 52-week-high of $148.99 and a 52-week-low of $121.00. Johnson & Johnson's stock last closed at $134.77 per share.
  • Nomura initiated coverage on KLA Corp KLAC with a Buy rating. The price target for KLA is set at $215.00. For the first quarter, KLA had an EPS of $2.48, compared to year-ago quarter EPS of $2.46. The current market cap for KLA is at $26.6 billion. The stock has a 52-week-high of $179.95 and a 52-week-low of $80.65. KLA's stock last closed at $175.99 per share.
  • Morgan Stanley initiated coverage on Lazard Ltd LAZ with an Underweight rating. The price target for Lazard is set at $35.00. Lazard earned $0.76 in the third quarter, compared to $0.86 in the year-ago quarter. The total market value of Lazard's outstanding shares is at $3.9 billion. The stock has a 52-week-high of $41.76 and a 52-week-low of $31.07. Lazard's stock last closed at $37.59 per share.
  • With a rating of Neutral, JP Morgan initiated coverage on LivePerson Inc LPSN. The price target is set at $40.00 for LivePerson. In the third quarter, LivePerson showed an EPS of ($0.36), compared to $0.02 from the year-ago quarter. The total market value of LivePerson's outstanding shares is at $2.6 billion. The stock has a 52-week-high of $42.85 and a 52-week-low of $16.98. LivePerson's stock last closed at $37.26 per share.
  • B. Riley FBR initiated coverage on Luxfer Holdings PLC LXFR with a Buy rating. The price target for Luxfer Holdings is set at $25.00. For the third quarter, Luxfer Holdings had an EPS of $0.36, compared to year-ago quarter EPS of $0.53. The current market cap for Luxfer Holdings is at $462.1 million. The stock has a 52-week-high of $26.25 and a 52-week-low of $14.65. Luxfer Holdings's stock last closed at $17.54 per share.
  • For MorphoSys AG MOR, Guggenheim initiated coverage, by setting the current rating at Buy. MorphoSys earned ($0.83) in the third quarter, compared to $1.09 in the year-ago quarter. The stock has a 52-week-high of $31.96 and a 52-week-low of $21.95. MorphoSys's stock last closed at $28.98 per share.
  • Citi initiated coverage on NexTier Oilfield Solutions Inc NEX with a Buy rating. The price target for NexTier Oilfield is set at $5.80. The total market value of NexTier Oilfield's outstanding shares is at $964.2 million. The stock has a 52-week-high of $12.50 and a 52-week-low of $4.05. NexTier Oilfield's stock last closed at $4.67 per share.
  • For Northwest Bancshares Inc NWBI, Raymond James initiated coverage, by setting the current rating at Market Perform. In the third quarter, Northwest Bancshares showed an EPS of $0.31, compared to $0.27 from the year-ago quarter. The total market value of Northwest Bancshares's outstanding shares is at $1.7 billion. The stock has a 52-week-high of $18.81 and a 52-week-low of $15.46. Northwest Bancshares's stock last closed at $16.76 per share.
  • Evercore ISI Group initiated coverage on Phathom Pharmaceuticals Inc PHAT with an Outperform rating. The stock has a 52-week-high of $28.51 and a 52-week-low of $20.26. Phathom Pharmaceuticals's stock last closed at $24.49 per share.
  • Deutsche Bank initiated coverage on Patterson-UTI Energy Inc PTEN with a Sell rating. The price target for Patterson-UTI Energy is set at $7.00. Patterson-UTI Energy earned ($0.27) in the third quarter, compared to ($0.10) in the year-ago quarter. Patterson-UTI Energy's market cap stands at $1.6 billion. The stock has a 52-week-high of $16.27 and a 52-week-low of $7.67. Patterson-UTI Energy's stock last closed at $8.47 per share.
  • Deutsche Bank initiated coverage on Transocean Ltd RIG with a Sell rating. The price target for Transocean is set at $3.00. For the third quarter, Transocean had an EPS of ($0.38), compared to year-ago quarter EPS of $0.06. The total market value of Transocean's outstanding shares is at $2.7 billion. The stock has a 52-week-high of $10.03 and a 52-week-low of $3.76. Transocean's stock last closed at $4.66 per share.
  • With a rating of Equal-Weight, Morgan Stanley initiated coverage on Raymond James Financial Inc RJF. The price target is set at $91.00 for Raymond James Financial. In the fourth quarter, Raymond James Financial showed an EPS of $2.00, compared to $1.68 from the year-ago quarter. The current market cap for Raymond James Financial is at $11.5 billion. The stock has a 52-week-high of $92.00 and a 52-week-low of $69.11. Raymond James Financial's stock last closed at $89.25 per share.
  • With a rating of Buy, Deutsche Bank initiated coverage on Schlumberger Ltd SLB. The price target is set at $42.00 for Schlumberger. Schlumberger earned $0.43 in the third quarter, compared to $0.46 in the year-ago quarter. The current market cap for Schlumberger is at $45.2 billion. The stock has a 52-week-high of $49.18 and a 52-week-low of $30.65. Schlumberger's stock last closed at $34.31 per share.
  • Craig-Hallum initiated coverage on Carrols Restaurant Group Inc TAST with a Buy rating. The price target for Carrols Restaurant Group is set at $11.00. Carrols Restaurant Group earned $0.09 in the third quarter, compared to $0.09 in the year-ago quarter. Carrols Restaurant Group's market cap stands at $363.9 million. The stock has a 52-week-high of $11.89 and a 52-week-low of $6.23. Carrols Restaurant Group's stock last closed at $7.39 per share.
  • Deutsche Bank initiated coverage on Valaris PLC VAL with a Hold rating. The current market cap for Valaris is at $815.3 million. The stock has a 52-week-high of $26.60 and a 52-week-low of $3.58. Valaris's stock last closed at $3.69 per share.
  • With a rating of Buy, Guggenheim initiated coverage on Exicure Inc XCUR. The price target is set at $9.00 for Exicure. For the second quarter, Exicure had an EPS of ($0.12), compared to year-ago quarter EPS of ($0.17). Exicure's market cap stands at $198.3 million. The stock has a 52-week-high of $4.20 and a 52-week-low of $1.62. Exicure's stock last closed at $2.60 per share.
  • With a rating of Buy, Guggenheim initiated coverage on Y-mAbs Therapeutics Inc YMAB. The price target is set at $40.00 for Y-mAbs Therapeutics. For the third quarter, Y-mAbs Therapeutics had an EPS of ($0.70), compared to year-ago quarter EPS of ($0.42). Y-mAbs Therapeutics's market cap stands at $1.0 billion. The stock has a 52-week-high of $32.90 and a 52-week-low of $15.17. Y-mAbs Therapeutics's stock last closed at $28.54 per share.
  • Guggenheim initiated coverage on Zymeworks Inc ZYME with a Buy rating. The price target for Zymeworks is set at $48.00. Zymeworks earned ($0.54) in the third quarter, compared to ($0.47) in the year-ago quarter. The total market value of Zymeworks's outstanding shares is at $1.3 billion. The stock has a 52-week-high of $38.30 and a 52-week-low of $10.72. Zymeworks's stock last closed at $38.29 per share.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsInformation TechnologyInitiationsInternet Software & Servicestop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!